GlobeNewsWire
26 Mar 2026, 20:02 UTC · 33w ago
Galapagos Announces Nomination of Gino Santini to its Board of Directors
Impact · against what's priced in
The nomination of Gino Santini as Board Chair is a mild positive for Galapagos, signaling a strategic shift toward aggressive M&A and business development. The appointment of a former Eli Lilly executive with a proven track record in acquisitions provides a tangible catalyst for the company's stated goal of identifying and acquiring promising opportunities.
- GLPG+0.20
No priced-in read yet




